HUTCHMED to Host Expert Call to discuss Immune Thrombocytopenia
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Aug. 21, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13)...
Pharmaceutical
Bioxodes reports positive DMC meeting for BIOX-101 Phase 2a trial in intracerebral hemorrhagic stroke
Planned Data Monitoring Committee (DMC) meeting recommended continuation of the study after reviewing data from the first 8 patients Interim data...
Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea
Allschwil, Switzerland, August 21, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs...
Regeneron Provides Update on Biologics License Application for Linvoseltamab
TARRYTOWN, N.Y., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and...
Codexis to Participate in Enzymatic Synthesis Presentations at RNA Leaders Annual Meeting
REDWOOD CITY, Calif., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced...
iZafe Group Secures Loan of SEK 5.5 million and Cancels Previously Issued Warrants of Series TO14B
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, BELARUS,...
Spago Nanomedical Interim Report January-June 2024
LUND, SE / ACCESSWIRE / August 21, 2024 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) Clinical and non-clinical progress in the Tumorad program...
Cosmos Health Reports Q2 2024 Results: Sustains Positive Momentum with 7% Revenue Growth vs. Q1 2023 and 12.5% vs. H1 2023
CHICAGO, IL / ACCESSWIRE / August 20, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,...
BioLogic Summit to Demystify the New AI/ML Paradigm in Biologic Drug Development
CHI's New Event to Support the Evolution of Hybrid Scientists in Biopharma R&D BOSTON, Aug. 20, 2024 /PRNewswire/ -- Biopharmaceutical...
IntegriChain Appoints Experienced High-Growth Finance Executive as CFO
PHILADELPHIA, Aug. 20, 2024 /PRNewswire/ -- IntegriChain, the leading provider of revenue optimization technology and insights for the pharmaceutical industry, today...
Clario publishes third annual ESG Report, reaffirms commitment to ethical AI, workforce investment, and sustainability targets
Clario's third annual ESG report for the calendar year 2023 highlights advancements in responsible artificial intelligence (AI), employee program investments,...
A New Reaction to Enhance Aromatic Ketone Use in Chemical Synthesis
Researchers develop a one pot process to transform aromatic ketones to esters, offering advancements in pharmaceutical synthesis and materials science....
MediLedger Partners With Prisma Health to Help Health System Enhance Pricing Accuracy and Contract Management
SAN FRANCISCO, CA / ACCESSWIRE / August 20, 2024 / The MediLedger network is excited to announce its partnership with...
Cosmos Health Reports Q1 2024 Results: Continues to Deliver Strong Growth and Improved Performance with 18% YoY Revenue Increase and 39% Rise in Gross Profit
CHICAGO, IL / ACCESSWIRE / August 20, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,...
Gilead Sciences: “One of Best Employers for Women” by Forbes
NORTHAMPTON, MA / ACCESSWIRE / August 20, 2024 / For the third year in a row, Forbes has recognized Gilead...
The CBD Vault Exploring China Distribution and JV Opportunities
SCOTTSDALE, AZ / ACCESSWIRE / August 20, 2024 / The landscape of the CBD industry in China is set to...
Telomir Pharmaceuticals Featured in Local ABC Exclusive Showing Positive Outcomes of Proposed Age Reversal Pill in Dogs
Promising results with Telomir-1 Demonstrates Potential in Promoting Life Quality and Longevity in Senior DogsTAMPA, FL / ACCESSWIRE / August...
iTeos Therapeutics Announces Late-Breaking Oral Presentation of Phase 2 GALAXIES Lung-201 Interim Data at the European Society for Medical Oncology Congress 2024
WATERTOWN, Mass. and GOSSELIES, Belgium, Aug. 20, 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS) (“iTeos”), a clinical-stage biopharmaceutical...
Roche responds to WHO’s declaration of a global health emergency due to the ongoing mpox outbreak
Roche is committed to supporting all those working to overcome the mpox outbreak by providing access to high-quality Polymerase Chain...
Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences
CORAL GABLES, Fla., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical...